Chen Zhigang, Eggerman Thomas L, Bocharov Alexander V, Baranova Irina N, Vishnyakova Tatyana G, Kurlander Roger, Patterson Amy P
From the Department of Laboratory Medicine, Clinical Center.
the Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, and.
J Biol Chem. 2017 Aug 11;292(32):13459-13479. doi: 10.1074/jbc.M116.760637. Epub 2017 Jun 21.
Apolipoprotein B mRNA-editing enzyme catalytic subunit 3 (APOBEC-3) enzymes are cytidine deaminases that are broadly and constitutively expressed. They are often up-regulated during carcinogenesis and candidate genes for causing the major single-base substitution in cancer-associated DNA mutations. Moreover, APOBEC-3s are involved in host innate immunity against many viruses. However, how APOBEC-3 mutational activity is regulated in normal and pathological conditions remains largely unknown. Heat shock protein levels are often elevated in both carcinogenesis and viral infection and are associated with DNA mutations. Here, using mutational analyses of hepatitis B virus (HBV), we found that Hsp90 stimulates deamination activity of APOBEC-3G (A3G), A3B, and A3C during co-expression in human liver HepG2 cells. Hsp90 directly stimulated A3G deamination activity when the purified proteins were used in reactions. Hsp40, -60, and -70 also had variable stimulatory effects in the cellular assay, but not Sequencing analyses further demonstrated that Hsp90 increased both A3G cytosine mutation efficiency on HBV DNA and total HBV mutation frequency. In addition, Hsp90 shifted A3G's cytosine region selection in HBV DNA and increased A3G's 5' nucleoside preference for deoxycytidine (5'-CC). Furthermore, the Hsp90 inhibitor 17--allylamino-17-demethoxygeldanamycin dose dependently inhibited A3G and A3B mutational activity on HBV viral DNA. Hsp90 knockdown by siRNA or by Hsp90 active-site mutation also decreased A3G activity. These results indicate that heat shock proteins, in particular Hsp90, stimulate APOBEC-3-mediated DNA deamination activity, suggesting a potential physiological role in carcinogenesis and viral innate immunity.
载脂蛋白B信使核糖核酸编辑酶催化亚基3(APOBEC-3)酶是广泛且组成性表达的胞苷脱氨酶。它们在致癌过程中常被上调,是癌症相关DNA突变中主要单碱基替换的候选基因。此外,APOBEC-3参与宿主对多种病毒的先天免疫。然而,APOBEC-3突变活性在正常和病理条件下如何被调控仍 largely未知。热休克蛋白水平在致癌和病毒感染过程中常升高,且与DNA突变相关。在此,通过对乙型肝炎病毒(HBV)的突变分析,我们发现在人肝癌HepG2细胞中共表达时,热休克蛋白90(Hsp90)刺激APOBEC-3G(A3G)、A3B和A3C的脱氨活性。当使用纯化蛋白进行反应时,Hsp90直接刺激A3G脱氨活性。热休克蛋白40、60和70在细胞试验中也有不同程度的刺激作用,但测序分析进一步表明,Hsp90增加了A3G对HBV DNA的胞嘧啶突变效率以及总HBV突变频率。此外,Hsp90改变了A3G在HBV DNA上的胞嘧啶区域选择,并增加了A3G对脱氧胞苷(5'-CC)的5'核苷偏好。此外,Hsp90抑制剂17-烯丙基氨基-17-去甲氧基格尔德霉素剂量依赖性地抑制A3G和A3B对HBV病毒DNA的突变活性。通过小干扰RNA或Hsp90活性位点突变敲低Hsp90也降低了A3G活性。这些结果表明热休克蛋白,尤其是Hsp90,刺激APOBEC-3介导的DNA脱氨活性,提示其在致癌和病毒先天免疫中具有潜在的生理作用。